Christopher Nishan Garabedian 4
4 · Sarepta Therapeutics, Inc. · Filed Aug 27, 2012
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Stock Appreciation Right
2012-08-23+70,000→ 70,000 totalExercise: $10.08Exp: 2022-08-23→ Common Stock (70,000 underlying) - Award
Stock Option (Right to Buy)
2012-08-23+150,000→ 150,000 totalExercise: $10.08Exp: 2022-08-23→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]25% of the shares subject to the stock appreciation right (SAR) will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.